Related references
Note: Only part of the references are listed.The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G. Cavaletti et al.
ANNALS OF ONCOLOGY (2013)
Prevention of chemotherapy-induced peripheral neuropathy: a matter of personalized treatment?
T. J. Postma et al.
ANNALS OF ONCOLOGY (2013)
Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
Ellen M. Lavoie Smith et al.
QUALITY OF LIFE RESEARCH (2013)
Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer
Naohiko Inoue et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
Wolfgang Grisold et al.
NEURO-ONCOLOGY (2012)
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
Sherry L. Wolf et al.
SUPPORTIVE CARE IN CANCER (2012)
Impact of oxaliplatin-induced neuropathy: a patient perspective
Barbara K. Bennett et al.
SUPPORTIVE CARE IN CANCER (2012)
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations
T. Luckett et al.
ANNALS OF ONCOLOGY (2011)
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale
Barbara Frigeni et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
Guido Cavaletti et al.
EUROPEAN JOURNAL OF CANCER (2010)
Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies
S. I. van Nes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2007)
Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies
I. S. J. Merkies et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
TJ Postma et al.
EUROPEAN JOURNAL OF CANCER (2005)
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale
G Cavaletti et al.
NEUROLOGY (2003)